MAP2K7 and breast cancer: Although hypoxia was able to activate multiple pathways in breast cancer cells only treatment with MEK inhibitors were able to reverse the hypoxia-mediated protective effect in lapatinib treated cells suggesting that the ERK pathway is critical for hypoxia-mediated lapatinib resistance.